Progression is accelerated from prehypertension to hypertension in blacks

Hypertension

Volumn 58, Issue 4, 2011, Pages 579-587

  Selassie, Anbesaw ^a   Wagner, C Shaun ^b   Laken, Marilyn L ^c   Ferguson, M Lafrance ^d   Ferdinand, Keith C ^e   Egan, Brent M ^b  

^a Divisions of Biostatistics ^*  (United States)

^b General Medicine   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Beaufort Jasper Hampton Comprehensive Health Services   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

black; hypertension; prehypertension; race

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CAUCASIAN; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ELECTRONIC MEDICAL RECORD; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; OBESITY; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PREHYPERTENSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES COMPLICATIONS; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PREHYPERTENSION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SOUTHEASTERN UNITED STATES; YOUNG ADULT;

EID: 80053560941     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.177410     Document Type: Article

References (44)

1. Robinson S, Brucer M. Range of normal blood pressure: a statistical and clinical study of 11,383 persons. Arch Int Med. 1939;64:409-444.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206-1252. (Pubitemid 37553153)
3. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685-1697.
4. Egan BM, Julius S. Prehypertension: risk stratification and management considerations. Curr Hypertens Rep. 2008;10:359-366.
5. Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A. Highnormal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension. 1991;17:22-27.
6. Winegarden CR. From "prehypertension" to hypertension? Additional evidence. Ann Epidemiol. 2005;15:720-725.
7. Egan B, Lackland D, Jones DW. Pre-hypertension: an opportunity for a new public health paradigm. In: Mensah GA, eds. Cardiology Clinics: Hypertension and Hypertensive Heart Disease. Philadelphia, PA: Saunders; 2010;561-569.
8. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303: 2043-2050.
9. Mensah GA. Eliminating disparities in cardiovascular health: six strategic imperatives and a framework for action. Circulation. 2005;111: 1332-1336. (Pubitemid 40389100)
10. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006;119:133-141. (Pubitemid 43151479)
11. Chobanian AV. Prehypertension revisited. Hypertension. 2006;48: 812-814. (Pubitemid 44610983)
12. Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA. Management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56: 780-800.
13. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med. 1997; 336:1117-1124.
14. Ford ES, Zhao G, Li C, Pearson WS, Mokdad AH. Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States. Am J Hypertens. 2008;21:1124-1128.
15. Mellen PB, Gao SK, Vitolins MZ, Goff DC Jr. Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004. Arch Intern Med. 2008;168: 308-314. (Pubitemid 351281678)
16. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure: age and pressure change over time. Hypertension. 1991;18: 67-71.
17. Egan B, Laken M, Wagner C, Mack S, Seymour-Edwards K, Dodson J, Zhao Y, Lackland DT. Impacting population cardiovascular health through a community-based practice network: update on an ASHsupported collaborative. J Clin Hypertension (Greenwich). 2011;13: 543-550.
18. SAS Institute Inc. Statistical Analytical Software. Version 9.1.3. Cary, NC: SAS Institute Inc; 2010.
19. Darlington GA. Collinearity. In: Armtage P, Colton T, eds. Encyclopedia of Biostatistics. Chichester, United Kingdom: John Wiley & Sons; 1998: 788-789.
20. Allison PD. Estimating and comparing survival curves with proc lifetest. In: The SAS Institute I, ed. Survival Analysis Using the SAS System: A Practical Guide. 1st ed. Cary, NC: SAS Institute, Inc; 1995:29-59.
21. Kleinbaum DG. Evaluating the proportional hazards assumption. In: Kleinbaum DG. Survival Analysis: A Self-Learning Text. 1st ed. New York, NY: Springer-Verlag; 2010:130-166.
22. Breslow NE, Day NE. Modelling the relaionship between risk, dose, and time. In: International Agency for Research on Cancer, ed. Statistical Method in Cancer Research: The Design and Analysis of Cohort Data. Lyon, France: Oxford University Press; 1987:232-270.
23. Greenland S. Applications of stratified analysis methods. In: Rothman KJ GSLT, ed. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:283-302.
24. Egan BM. Should metabolic syndrome patients with prehypertension receive antihypertensive therapy? In: Bakris GL, ed. Therapeutic Strategies in Hypertension. Oxford, United Kingdom: Clinical Publishing; 2006:9-25.
25. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation. 2007;115:855-860. (Pubitemid 46294726)
26. Liszka HA, Mainous AG III, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005;3: 294-299. (Pubitemid 41176304)
27. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension. 2000;35:539-543. (Pubitemid 30108145)
28. Tsai SP, Wen CP, Chan HT, Chiang PH, Tsai MK, Cheng TY. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality. Diabetes Res Clin Pract. 2008;82: 148-156.
29. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
30. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, Howard BV. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension. 2006; 47:410-414. (Pubitemid 43740283)
31. Bogaert YE, Linas S. The role of obesity in the pathogenesis of hypertension. Nat Clin Pract Nephrol. 2009;5:101-111.
32. Hall JE, Jones DW, Kuo JJ, da SA, Tallam LS, Liu J. Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep. 2003;5:386-392. (Pubitemid 38898962)
33. Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens. 1994;12:1433-1437.
34. Smulyan H. Clinical studies and therapeutic trials in systolic hypertension. Pathol Biol (Paris). 1999;47:752-759.
35. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med. 2002;162:577-581. (Pubitemid 34193545)
36. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005;36: 1859-1863. (Pubitemid 41266514)
37. Smulyan H, Safar ME. Systolic blood pressure revisited. J Am Coll Cardiol. 1997;29:1407-1413. (Pubitemid 27272430)
38. Smulyan H, Safar ME. The diastolic blood pressure in systolic hypertension. Ann Intern Med. 2000;132:233-237. (Pubitemid 30064924)
39. Whyte JL, Lapuerta P, L'Italien GJ, Franklin SS. The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988-1994. J Clin Hypertens (Greenwich). 2001;3:211-216. (Pubitemid 32747167)
40. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with highnormal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157:657-667.
41. Link CL, McKinlay JB. Disparities in the prevalence of diabetes: is it race/ethnicity or socioeconomic status? Results from the Boston Area Community Health (BACH) Survey. Ethn Dis. 2009;19:288-292.
42. Williams DR, Mohammed SA, Leavell J, Collins C. Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci. 2010;1186:69-101.
43. National Center for Health Statistics. Healthy People 2000 Final Review. http://www.dc.gov/nchs/data/hp2000/hp2k01.pdf. 2001. Accessed March 23, 2010.
44. Healthy People 2010. Heart Disease and Stroke. http://www.dc.gov/dhdsp/ docs/hp2010.pdf. 2010. Accessed May 6, 2010.